BioCryst Pharmaceuticals
BCRX
BCRX
285 hedge funds and large institutions have $1.48B invested in BioCryst Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 94 increasing their positions, 107 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 294 → 285 (-9)
12% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 107
17% less capital invested
Capital invested by funds: $1.77B → $1.48B (-$292M)
Holders
285
Holding in Top 10
1
Calls
$6.78M
Puts
$4.9M
Top Buyers
| 1 | +$56.8M | |
| 2 | +$18M | |
| 3 | +$11.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.88M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$9.46M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$20.3M | |
| 3 | -$15.7M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$11.5M |
| 5 |
Millennium Management
New York
|
-$11M |
